Boehringer partners with Simcere to develop a bispecific antibody that simultaneously inhibits two drivers of inflammatory bowel disease....
This move is part of a business optimization process that responds to changes in consumer behavior and the retail environment Read Full Article →
How can investors tell the difference between a real value-creating transformation and “compliance theater”? Read Full Article →
Investment Analysts’ new coverage for Friday, March 27th: BMO Capital Markets assumed coverage on shares of AMETEK (NYSE:AME). BMO Capital Markets issued an outperform rating and a $253.00 target price on the stock. Stephens initiated coverage on shares of Associated Banc (NYSE:ASB). The firm issued an overweight
Analysts’ upgrades for Friday, March 27th: Argan (NYSE:AGX) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. JPMorgan Chase & Co. currently has $550.00 target price on the stock. Bilibili (NASDAQ:BILI) was upgraded by analysts at Citigroup Inc. from
